Condition: Inflammatory Cardiomyopathy · Myocarditis · Sponsor: Tongji Hospital
Evaluating the long-term therapeutic effects and safety of hydroxychloroquine(compared to glucocorticoid therapy alone) in patients with inflammatory cardiomyopathy--a multicenter randomized controlled study
This description comes directly from the study's public registry record.
Dao Wen Wang, MD, PhD · +86-027-6937-8422 · dwwang@tjh.tjmu.edu.cn
Wu He · +8613972334305 · hewu0912@163.com
Always discuss trial participation with your own doctor first.
| Tongji Hospital | Wuhan, Hubei, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05961202